Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PROCEPT BioRobotics (PRCT) Research & Development (2020 - 2025)

PROCEPT BioRobotics has reported Research & Development over the past 6 years, most recently at $19.1 million for Q4 2025.

  • Quarterly results put Research & Development at $19.1 million for Q4 2025, up 26.48% from a year ago — trailing twelve months through Dec 2025 was $71.3 million (up 14.41% YoY), and the annual figure for FY2025 was $71.3 million, up 14.41%.
  • Research & Development for Q4 2025 was $19.1 million at PROCEPT BioRobotics, up from $18.2 million in the prior quarter.
  • Over the last five years, Research & Development for PRCT hit a ceiling of $19.1 million in Q4 2025 and a floor of $4.5 million in Q2 2021.
  • Median Research & Development over the past 5 years was $11.6 million (2023), compared with a mean of $11.5 million.
  • Biggest five-year swings in Research & Development: surged 114.27% in 2023 and later grew 0.75% in 2025.
  • PROCEPT BioRobotics' Research & Development stood at $5.1 million in 2021, then soared by 90.74% to $9.7 million in 2022, then surged by 49.72% to $14.5 million in 2023, then rose by 3.93% to $15.1 million in 2024, then grew by 26.48% to $19.1 million in 2025.
  • The last three reported values for Research & Development were $19.1 million (Q4 2025), $18.2 million (Q3 2025), and $17.6 million (Q2 2025) per Business Quant data.